Delivery Order SPE2DB22D2009-SPE2DB25FL6HL

Award Date 11/6/24
Potential Completion Date 11/7/24
Potential Value $2.9K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The award, valued at $1,998.10, covers the delivery of PROLENSA 0.07% eye drops (3ml) and has a completion date of September 12, 2023. The contract is a Delivery Order type with a Firm Fixed Price pricing structure. It is not designated as a set-aside contract. Amerisourcebergen Drug Corp is a subsidiary of the parent...
This is a federal contract award from the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $5,564.48 Firm Fixed Price Delivery Order contract is for the supply of PROLENSA 0.07% eye drops (3mL). The contract has a completion date of November 7, 2024. Amerisourcebergen holds a larger $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a...
This federal contract award, valued at $2,564.94, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of PROLENSA 0.07% eye drops with an ultimate completion date of January 28, 2025. The contract is a Delivery Order with a Firm Fixed Price pricing type. This award is not associated with a set-aside program and appears to be part of a larger Indefinite Delivery...
This is a federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of PROLENSA 0.07% eye drops, a prescription medication, with a ceiling value of $1,241.13 and a completion date of December 14, 2023. This is a Firm Fixed Price (FFP) Delivery Order contract, which indicates it is part of a larger Indefinite Delivery Contract (IDC) vehicle with the DLA....
This federal contract award is from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, for the delivery of 4,555,355,594 units of PROLENSA 0.07% eye drops in 3 milliliter vials. The firm-fixed-price delivery order, valued at $16,328.27, has a period of performance through November 9, 2021. This award is not designated as a set-aside contract. The contract is part of a larger Indefinite Delivery Contract (IDC)...
This is a firm fixed-price delivery order issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The $2,975.54 contract is for the supply of PROLENSA 0.07% eye drops. The contract has a period of performance through May 6, 2025 and does not have a set-aside designation, indicating open competition. AmerisourceBergen holds a larger $999,999,999.00 Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, which provides a...
This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of PROLENSA 0.07% eye drops. The firm-fixed-price contract, valued at $3,039.35, has a period of performance through July 10, 2023. AmerisourceBergen holds a larger $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a vehicle for providing a comprehensive range of pharmaceutical products and...
This is a federal contract award from the Defense Logistics Agency (DLA) Troop Support Medical to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the procurement of PROLENSA 0.07% eye drops, a specialty pharmaceutical product, with a ceiling value of $1,261.70. This is a delivery order contract with a firm fixed price pricing type, and the ultimate completion date is October 11, 2023. The contract award is not associated with...
This is a delivery order issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corporation, a major pharmaceutical distributor. The $2,487.42 firm fixed-price contract is for the delivery of PROLENSA 0.07% eye drops, with a completion date of January 17, 2023. The award does not have a set-aside designation, indicating open competition. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a primary...
This federal contract award, valued at $7,455.04, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of 4560410185 PROLENSA 0.07% eye drops, a specialty pharmaceutical product, with a period of performance through March 29, 2023. This delivery order is under an Indefinite Delivery Contract (IDC) held by Amerisourcebergen with the DLA Troop Support Medical, which...
  • SPE2DB22D2009
    Indefinite Delivery Contract
  • SPE2DB22D2009-SPE2DB25FL6HL
    Delivery Order

This federal contract award, valued at $2,857.91, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of PROLENSA 0.07% eye drops, a pharmaceutical product, and has a completion date of November 7, 2024.

The contract is a Delivery Order, with a Firm Fixed Price pricing type, and is not designated with any set-aside requirements, indicating open competition. AmerisourceBergen Drug Corp is the prime contractor, and the contract is associated with a larger Indefinite Delivery Contract (IDC) that the company holds with the DLA Troop Support Medical, valued at $999,999,999 and running through November 2026. This IDC serves as a primary vehicle for providing a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs globally.

Generated 5/20/25, 2:07 PM